GOLDMAN SACHS GROUP INC - PHARMERICA CORP ownership

PHARMERICA CORP's ticker is PMC and the CUSIP is 71714F104. A total of 158 filers reported holding PHARMERICA CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PHARMERICA CORP
ValueSharesWeighting
Q3 2017$12,320,000
+1037.6%
420,462
+918.9%
0.00%
Q2 2017$1,083,000
-42.0%
41,265
-48.3%
0.00%
-100.0%
Q1 2017$1,867,000
-33.1%
79,794
-28.0%
0.00%0.0%
Q4 2016$2,789,000
+166.9%
110,878
+198.0%
0.00%
Q3 2016$1,045,000
-72.2%
37,211
-75.6%
0.00%
-100.0%
Q2 2016$3,754,000
+0.4%
152,232
-10.0%
0.00%0.0%
Q1 2016$3,738,000
-42.6%
169,053
-9.1%
0.00%
-50.0%
Q4 2015$6,508,000
+14.4%
185,937
-7.0%
0.00%0.0%
Q3 2015$5,690,000
+517.1%
199,868
+621.9%
0.00%
Q2 2015$922,000
-81.2%
27,686
-84.0%
0.00%
-100.0%
Q1 2015$4,892,000
+1698.5%
173,544
+1220.6%
0.00%
Q4 2014$272,000
-93.9%
13,141
-92.8%
0.00%
-100.0%
Q3 2014$4,465,000
-19.9%
182,752
-6.3%
0.00%
-50.0%
Q2 2014$5,575,000
-7.9%
195,025
-9.8%
0.00%0.0%
Q1 2014$6,050,000
-0.3%
216,228
-23.4%
0.00%0.0%
Q4 2013$6,066,000
+109.5%
282,133
+29.3%
0.00%
+100.0%
Q3 2013$2,896,000
+87.8%
218,270
+96.2%
0.00%0.0%
Q2 2013$1,542,000
-67.5%
111,227
-66.7%
0.00%
-50.0%
Q4 2012$4,750,000
+30.9%
333,560
+16.3%
0.00%
+100.0%
Q3 2012$3,630,000
+15.5%
286,719
-0.4%
0.00%0.0%
Q2 2012$3,143,000
+20.3%
287,781
+36.8%
0.00%0.0%
Q1 2012$2,613,000210,2920.00%
Other shareholders
PHARMERICA CORP shareholders Q1 2015
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 655,900$18,352,0002.28%
Smith, Graham & Co., Investment Advisors, LP 526,050$14,719,0002.13%
Personal Capital Advisors Corp 161,683$4,524,0001.02%
HEARTLAND ADVISORS INC 1,803,533$50,463,0000.88%
Manatuck Hill Partners, LLC 195,000$5,456,0000.87%
THB ASSET MANAGEMENT 315,878$8,838,0000.53%
FULLER & THALER ASSET MANAGEMENT, INC. 368,033$10,298,0000.50%
ALGERT GLOBAL LLC 44,566$1,247,0000.49%
Century Capital Management, LLC 328,142$9,181,0000.43%
LEUTHOLD GROUP, LLC 151,416$4,237,0000.38%
View complete list of PHARMERICA CORP shareholders